This chapter explores the pharmaceutical industry's reactions to Medicare price negotiation reforms, emphasizing concerns over innovation and public awareness of these changes. It also discusses Walmart's strong earnings amidst inflationary pressures, contrasting its success with broader retail trends. Additionally, the chapter raises alarms about the implications of Elon Musk's AI developments, particularly regarding misinformation and content moderation challenges.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode